אלדן וחברת Agilent technologies – Seahorse עורכות יום עיון בנושא:
Measuring Metabolic Engines and Fuels with the Agilent Seahorse XF Analyzers
יום העיון ייערך ביום חמישי, 18 במאי, 2017 בין השעות 08:30-15:30 במכון ויצמן, חדר סמינרים בניין קנדיוטי.
ההשתתפות ללא תשלום, אך נדרשת הרשמה מראש.
מספר המקומות מוגבל.
מה בתוכנית?
08:30-09:00 Coffee and welcome
09:00-09:15 Opening: Dr. Elena Ainbinder, Head of Stem Cell Core and Advanced Cell Technologies Unit,
Dept. of Life Sciences Core Facilities, Weizmann Institute of Science.
09:15–09:45 Discovering Bioenergetic Anticancer Targets in vitro
Prof. Richard K. Porter, Head of Biochemistry School of Biochemistry & Immunology,
Trinity College Dublin, Ireland.
09:45–10:15 The onco-metabolic role and liabilities of the TCA cycle in cancer
Prof. Eyal Gottlieb, Laura and Isaac Perlmutter National Metabolomics Center, TICC, Technio.n
10:15–10:45 The world’s most powerful metabolic analyzers and assays Dr. Svetoslav Kalaydjiev, Agilent Technologies, Inc.
10:45–11:15 Coffee break
11:15–11:45 The workflow involved in deciphering mitochondrial dysfunction
Prof. Orian Shirihai, Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University.
11:45–12:15 MTCH2: A new regulator of mitochondria function in homeostasis and stress
Prof. Atan Gross, Department of Biological Regulation, Weizmann Institute of Science.
12:15–12:45 Circadian control of mitochondrial function
Dr. Gad Asher, Department of Biological Chemistry, Weizmann Institute of Science.
12:15–14:00 Lunch
14:00-14:15 Investigation of changes in metabolism during spermatogenesis
Dr. Nina Mayorek, Prof. Eli Pikarsky lab, Immunology and Cancer Research, Medical School, Hebrew University of Jerusalem.
14:15-14:30 eIF2B links translational control to mitochondrial aerobic respiration in VWM disease
Melisa Herrero, Prof Orna Elroy-Stein Lab, Department of Cell Research and Immunology,
Faculty of Life Sciences, Tel Aviv University.
14:30-14:45 Seahorse: Artifacts and Other Mysteries
A.O. Saragov, Dr. Michael Berger Lab, Department of Immunology and Cancer Research, Hebrew University Medical School.
